Filing Details

Accession Number:
0000899243-21-031086
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-02 20:02:54
Reporting Period:
2021-07-29
Accepted Time:
2021-08-02 20:02:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841387 Candel Therapeutics Inc. CADL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1816992 Nathan Caffo C/O Candel Therapeutics, Inc.
117 Kendrick St., Suite 450
Needham MA 02494
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-29 6,000 $8.00 6,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct